Neighbourly Pharmacy Inc
TSX:NBLY
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
CA |
Neighbourly Pharmacy Inc
TSX:NBLY
|
831.9m CAD | 13.6 | ||
ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
76B Zac | 0 | |
ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
27.8B Zac | 0 | |
US |
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
13.4B USD | 4.8 | ||
BR |
Raia Drogasil SA
BOVESPA:RADL3
|
44.1B BRL | 12.3 | ||
JP |
MatsukiyoCocokara & Co
TSE:3088
|
880.6B JPY | 7.8 | ||
SA |
Al Nahdi Medical Company SCJSC
SAU:4164
|
17.2B SAR | 11.1 | ||
MX |
Corporativo Fragua SAB de CV
BMV:FRAGUAB
|
81.2B MXN | 7.7 | ||
CN |
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
30B CNY | 16.1 | ||
JP |
Cosmos Pharmaceutical Corp
TSE:3349
|
491.4B JPY | 9.6 | ||
JP |
Sundrug Co Ltd
TSE:9989
|
450.1B JPY | 7.4 |
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.